Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

806.20INR
3:52pm IST
Price Change (% chg)

Rs7.25 (+0.91%)
Prev Close
Rs798.95
Open
Rs801.10
Day's High
Rs814.00
Day's Low
Rs791.00
Volume
1,085,979
Avg. Vol
1,900,748
52-wk High
Rs887.00
52-wk Low
Rs336.55

WCKH.NS

Chart for WCKH.NS

About

Wockhardt Limited is a pharmaceutical and biotechnology Company. The Company offers care in cardiology, cardiac surgery, neurology, neurosurgery, orthopedics and joint replacement surgery. Other specialities include minimal access surgery, nephrology, urology, critical care, medical and surgical oncology and emergency services... (more)

Overall

Beta: 0.69
Market Cap (Mil.): Rs87,890.81
Shares Outstanding (Mil.): 110.01
Dividend: 5.00
Yield (%): 1.41

Financials

  WCKH.NS Industry Sector
P/E (TTM): 16.41 33.37 34.07
EPS (TTM): 48.67 -- --
ROI: -- 18.15 17.40
ROE: -- 18.85 18.25
Search Stocks

Wockhardt Q4 profit down 78 percent on import bans

MUMBAI - Drugmaker Wockhardt Ltd on Monday reported a 78 percent slump in March-quarter profit, as it continues to reel under the U.S. and U.K. import bans due to manufacturing quality lapses.

26 May 2014

Wockhardt denies media report on asset sale talks

MUMBAI - Generic drugmaker Wockhardt Ltd denied on Tuesday a media report that said U.S. drugmakers Mylan Inc and Pfizer Inc were in talks with the company to buy some of its assets.

29 Apr 2014

Wockhardt denies media report on asset sale talks

MUMBAI, April 29 - Indian generic drugmaker Wockhardt Ltd denied on Tuesday a media report that said U.S. drugmakers Mylan Inc and Pfizer Inc were in talks with the company to buy some of its assets.

29 Apr 2014

Wockhardt says Himachal regulator lifts drug ban

MUMBAI - Generic drugmaker Wockhardt Ltd said on Monday the drug regulator of Himachal Pradesh has revoked a suspension it imposed on the manufacture and sale of a combination drug for pain treatment.

28 Apr 2014

India's Wockhardt says state regulator lifts drug ban

MUMBAI, April 28 - Indian generic drugmaker Wockhardt Ltd said on Monday the drug regulator of the northern Indian state of Himachal Pradesh has revoked a suspension it imposed on the manufacture and sale of a combination drug for pain treatment.

28 Apr 2014

CORRECTED-UPDATE 1-FDA finds contaminated drug ingredients at GSK Ireland plant

(Corrects last paragraph to say that one Sun Pharma plant and some Wockhardt plants have been barred from exporting drugs to the US. The incorrect version suggested that all Sun Pharma and Wockhardt plants were barred)

01 Apr 2014

Earnings vs. Estimates

Search Stocks